Evonik
2022년 05월 25일 Wednesday
2:00 p.m. KST / 1:00 a.m. EDT

제4회 제제 기술 포럼 / 4th Korean Forum on Pharmaceutical Formulation Technology

메인 페이지로 돌아가기

개요

지난 100년 간 제약산업의 눈부신 발전은 인류에게 더 좋은 의약품을 기반으로 한 건강한 사회를 구축하고 미래 번영을 약속하는 기반이 되었습니다. 더 많은 연구와 과학적탐구에 따라 많은 NCE들이 등장하였으나 이들 중 상당수는 낮은 용해도나 생체이용률 등의 문제로 인하여 상업화하는 데에 어려움을 겪고 있고, 기존 의약품들의 용해도 개선이나 원하는 정확한 absorption window를 타게팅하는 기술 등의 요구는 갈수록 커지고 있으며, 이러한 것들은 제제연구원들에게 있어 주요한 연구 목표가 되고 있습니다.

Evonik Health Care는 60년 이상의 역사를 가진 Functional excipient인 EUDRAGIT®과 25년 이상의 역사를 가진 Polymeric microparticle 기술 등을 기반으로 다양한 제제학적 요구에 대응할 수 있는 제제기술을 보유하고 있습니다.
따라서 이러한 시대적 요구에 대응 가능한 제제기술들을 한국 내 제제 연구원들에게 소개하고, 의약품의 개발과 처방/공정 기술에 적용할 수 있는 기술적 아이디어와 예시 등을 공유하는 제제기술포럼을 준비하였습니다.

이 포럼에서는 Functional pharmaceutical polymer, advanced GI targeting formulation technologies, drug solubility enhancement, enteric drug delivery 그리고 유동층 공정 기술 등에 대한 상세한 정보와 case study 등이 공유될 것이며, 또한 참가자들은 실시간으로 질문을 채팅창에 남겨 실시간 또는 발표 후 이메일로 질의에 대한 상세한 답변을 받을 수가 있을 것입니다.
한국약제학회와 공동 주최하는 이 포럼은 경구 의약품을 연구하는 연구원과 개발자들에게 있어, 많은 insight와 정보를 얻을 수 있는 좋은 기회가 될 것입니다.

The remarkable development of the pharmaceutical industry over the past 100 years has laid the foundation for building a healthy society based on better medicines and promising future prosperity. Many NCEs have emerged as a result of more technical and scientific research, but many of them are having difficulties in commercialization due to problems such as low solubility or low bioavailability, and needs on the targeting the accurate absorption window is getting increased. The demand for pharmaceuticals is growing, and these are becoming major research goals for pharmaceutical researchers.

Evonik Health Care has formulation/process technology that can respond to various pharmaceutical needs based on EUDRAGIT®, a functional excipient with over 60 years of history, and polymeric microparticle technology with over 25 years of history.
Therefore, we prepared a formulation technology forum to introduce formulation technologies that can respond to the needs of the times to formulation researchers in South Korea, and to share technical ideas and examples applicable to drug development and formulation/processing technology.

In this webinar, detailed information and case studies on functional pharmaceutical polymers, advanced GI targeting formulation technologies, drug solubility enhancement, enteric drug delivery, and fluidized bed processing technology will be shared. Attendees can post their questions in live chat during the presentation, and the presenter will respond via email after the presentation or at a later date.
This forum, co-hosted by the Korean Society of Pharmaceutical Sciences and Technology(KSPST), will be a great opportunity for researchers and developers who works oral pharmaceuticals to gain insight and cutting-edge technology.

발표자 리스트

Felix Hofmann
Director Formulation & Application Services EMEA
Evonik Health Care

약력
Felix Hofmann is director of the Formulation & Application Services EMEA at Evonik Health Care. He is based in Darmstadt, Germany and is responsible for customer-centric and holistic technical support for the health care industry.

Felix began his career in 2002 at Röhm (now Evonik) as a lab technician and in 2015 completed a degree in process engineering specializing in pharmaceutical technology at the University of Applied Science in Bingen, Germany.

Throughout his time at Evonik, Felix has held multiple roles as a senior and principal scientist, handling customer requests, customer projects and process troubleshooting during scale-up and production of coated particles or tablets. He also has experience working on complex customer projects including GMP and HPAPI requirements.

Felix has published several papers and posters on the application of pharmaceutical methacrylates in the formulation of solid dosage forms and is co-inventor of several patents.
Tatsuya Ishii 石井達弥
Technical Service Manager 技術サービスマネジャー
약력
Tatsuya Ishii graduated from Nihon University, College of Pharmacy in 2005.
He completed a masters course in 2007 at the same University in the field of solubility enhancement of poorly water soluble drugs by co-grinding methods.
In 2007, he Joined Degussa Japan Co., Ltd. (now Evonik Japan Co., Ltd.) and has been engaging in technical services mainly for development of oral solid dosage forms.

エボニックジャパン株式会社
ヘルスケア部 筑波工場・テクノロジーセンター
技術サービスマネジャー

2005年 日本大学薬学部卒業
2007年 日本大学大学院 薬学研究科 修士課程修了
同年4月  デグサジャパン株式会社(現エボニックジャパン株式会社)入社
経口固形製剤や健康食品を主とする技術サービスに従事
Hans Bär
Head of Global Oral Drug Delivery Services
Evonik Health Care

약력
Hans is responsible for the global project portfolio of Evonik’s oral drug delivery business. He has extensive experience in the use of functional polymers and oral drug delivery technologies to protect the API, improve targeting and boost drug performance.

One core area of expertise is the use of drug delivery technologies for precise colonic targeting. Hans is the author and co-author of several patent applications and a dozen scientific articles and posters about the application and formulation of pharmaceutical applied polymethacrylates for the preparation of oral solid dosage forms.

He has a degree in pharmaceutical process engineering from the Technical University Bingen, and a Master’s in pharmaceutical medicine from the University of Dusiburg-Essen.
Alexander Bernhardt
Head of Drug Delivery & Applications
Evonik Health Care

약력
• Head of Drug Delivery & Applications
• Pharmacy diploma from University of Regensburg, Germany
• Expert in parenteral and oral drug delivery technologies
• Experience in drug nanosuspensions of poorly water-soluble drugs
Hisao Matsuka
Vice President – Asia Pacific, Sales & Services
Evonik Health Care

약력
Hisao Matsuka joined Evonik Health Care as Vice President Asia North & Oceania in April 2021. He is presently responsible for sales & services activities in the region Asia Pacific for the business line Health Care at Evonik's Nutrition & Care Division.

He started his career in 1997 as an R&D Engineer, Electronics Lab/Software Development at Toyota Motor Corporation. Later he took up the responsibility as Program Manager, Global CT Business / Integration Manager, Asia Pacific at GE Healthcare (formerly GE Medical Systems).

Matsuka also served Manager & Director positions at Abbott Diabetes Care, Abbott Laboratories and as Director, New Product Introduction Japan / Project Director, Asia Pacific Manufacturing at Baxter International. Before joining Evonik, he was associated with Fresenius Kabi as their General Manager Japan.

Matsuka holds the degree of Bachelor of Science in Electrical Engineering from California State Polytechnic University, California, USA and Master of Engineering (Electrical Engineering) from Cornell University, New York, USA.
[축사] Ph.D. Yu-Kyoung Oh
President
Korean Society of Pharmaceutical Sciences and Technology

약력
Dr. Yu-Kyoung Oh is dean of College of Pharmacy at Seoul National University, Republic of Korea. She has been a fellow of the Korean Academy Science and Technology (KAST) since 2014. She received bachelor and master degrees from Seoul National University, and Ph.D. degree from State Univ. of New York at Buffalo in 1994. She obtained postdoctoral training at Harvard Medical School (1994-1996).

Her research interests focus on delivery of chemical drugs and nucleic acid-based drugs using versatile nanobiomaterials. She has published more than 220 SCI papers and granted 26 patents. She is involved in editorial activity for leading journals in pharmaceutical field. She currently serves as a deputy Editor-in-Chief of the Journal of Controlled Release, an executive editor of Advanced Drug Delivery Review, and a review editor for Drug Delivery and Translational Research. She has been serving as a Director-at-Large of Controlled Release Society since 2020, president of the Korean Society of Pharmaceutical Sciences and Technology, and president of Korean Association of Pharmacy Education.

Professor Oh also serves as a leader of the 4th BK21 project (Pharmacy Education and Research Center for Future-Innovating Global Leaders). She is a recipient of an excellent research award from Seoul National University (2015), Yoon Kwang Yeol research award from the Pharmaceutical Society of Korea (2018), Hwandang award from KAST (2018), and Seoul Culture Award from the mayor of Seoul (2019).
Dr. Marc Michaelis
Head of Pharma Service Schopfheim
Hüttlin GmbH, a Syntegon company

약력
TBD

프로그램

본 워크샵에서 다루어질 주제는:
  • Evonik Health Care – Your Competitive Advantage: Evonik Health Care의 제품과 서비스에 대한 간략한 소개
  • Functional Pharma polymers and Technical support: 제약용 기능성 고분자들에 대한 소개 및 적용 기술에 대한 소개
  • Advanced GI targeting formulation technologies: 최신 GI targeting formulation에 대한 상세한 기술 소개
  • Drug solubility enhancement: Microparticle을 적용한 최신의 의약품 용해도 향상 기술 소개
  • Pellet Coating Unchained: Hüttlin 유동층 장비를 기반으로 한 유동층 공정 소개 및 케이스 스터디
  • Superior way for an Enteric oral drug delivery: 장용성 캡슐인 EUDRACAP®의 소개 및 케이스 스터디

지금 참가 신청하세요!

A first impression of what you can expect at our webinar:
  • Welcome Speech: President of KSPST
  • Evonik Health Care - Your Competitive Advantage
  • Functional Pharma polymers and Technical support
  • Advanced GI targeting formulation technologies
  • Drug solubility enhancement
  • Pellet Coating Unchained: Hüttlin
  • Superior way for a Enteric oral drug delivery

Join us!

지금 등록하십시오

세부사항

언어
영어와 한국어

장소

온라인

질문이 있으십니까?

박승우 부장
Business Manager
+82 2 320 4791 이메일
지금 등록하십시오
Evonik Health Care
Company Information
Legal Notice
Privacy Policy